Early access to innovative medicines (EAM) is a crucial mechanism in the healthcare sector, particularly in France, allowing patients to quickly benefit from new treatments even before their official marketing authorization.
Discover how the pharmaceutical industry is addressing global drug shortages, exploring the complex causes and innovative strategies implemented to ensure continuity of care.
Innovation in the healthcare sector is driven by key players who are shaping the future of medical care. Pharmafield stands out as a key player in this transformation, leveraging technology and human expertise to optimize the care pathway.
February 29, 2024, marks an important date in the global health calendar: International Rare Disease Day. This day has a crucial goal: to raise awareness and mobilize support for the millions of people affected by rare diseases across the globe.
The regulations surrounding the products that can be listed and sold in pharmacies are both strict and dynamic, evolving in line with scientific advances, public health needs, and European directives.
The importance of vaccination against seasonal flu and COVID-19 cannot be underestimated. With both viruses circulating simultaneously, it is crucial that we take steps to protect ourselves and our community.
The pharmaceutical industry, by its very nature, is constantly evolving. At the intersection of research, innovation, and care, it is also faced with constant regulatory changes.